CTT Correios de Portugal SA (CTT)
Euronext Lisbon · Portugal · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 5.410 |
|---|---|
| 52-week range | 5.390 – 7.680 |
| Return, 1 month / 3 months | −14.3% / −8.7% |
| Return, 1 year / 3 years | −22.2% / +73.0% |
| Trend | Below its 200-day average |
| RSI (14) | 25 |
| Volatility (1 year) | 27.7% |
| Worst drawdown (1 year) | -26.5% |
| Average daily value traded | 2.13M EUR |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CTT Correios de Portugal is the Portuguese postal and logistics company based in Lisbon. It handles letter mail, parcels and express delivery for households, businesses and public bodies across Portugal, and it runs a nationwide network of post offices and retail points. Through that network it also offers financial and payment services, including savings products and bill payments, alongside its mail and parcel operations.
The shares are listed on the Euronext Lisbon in Portugal under the code CTT, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CTT Correios de Portugal SA (CTT) trades on the Euronext Lisbon in Portugal. It last closed at EUR 5.410 on 23 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 30 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 22.2% and over the last three months it fell 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.4% | ||
| From 52-week high | -28.7% | ||
| Momentum | 17 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.7% | ||
| 6-month return | -13.0% | ||
| 12-month return, skipping the last month | -9.3% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.5% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 2.13M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.3% |
|---|---|
| 1 month | −14.3% |
| 3 months | −8.7% |
| 6 months | −13.0% |
| 1 year | −22.2% |
| 3 years | +73.0% |
| 5 years | +26.8% |
Signals
| 50-day / 200-day average | 6.132 / 6.246 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.111 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | EUR 0.1900 |
| 13 May 2025 | EUR 0.1700 |
| 14 May 2024 | EUR 0.1700 |
| 17 May 2023 | EUR 0.1250 |
| 18 May 2022 | EUR 0.1200 |
| 18 May 2021 | EUR 0.0850 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.